_id
6911b3dbccc777a4e85d5fa6
Ticker
FNCH
Name
Finch Therapeutics Group Inc
Exchange
PINK
Address
75 State Street, Boston, MA, United States, 02109
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://www.finchtherapeutics.com
Description
Finch Therapeutics Group, Inc., a clinical-stage microbiome therapeutics company, develops a novel class of orally administered biological drugs in the United States. The company develops FIN-211, a microbiome candidate designed to address the gastrointestinal and behavioral symptoms of autism spectrum disorder; and FIN-524 for the prevention, diagnosis, theragnosis or treatment of diseases in humans, including ulcerative colitis; FIN-525 for the treatment of Crohn's disease; and other microbiome product candidates. The company has collaboration and license agreements with Takeda Pharmaceutical Company Limited; and license agreements with Skysong Innovations LLC, OpenBiome, Arizona State University, and University of Minnesota. Finch Therapeutics Group, Inc. was incorporated in 2014 and is based in Boston, Massachusetts.
Last Close
13.7
Volume
-
Current Price
13.56
Change
-1.0218978102189693
Last Updated
2025-11-30T18:52:38.062Z
Image
data:image/webp;base64,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
Ipo Date
2021-03-19T00:00:00.000Z
Market Cap
21685844
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Rating
4
Target Price
90
Strong Buy
0
Buy
1
Hold
0
Sell
0
Strong Sell
0
Current Quarter
2024-06-30
Revenue
0
Cost Of Revenue
44000
Gross Profit
-44000
Operating Expenses
6109000
Operating Income
-6109000
Interest Expense
-
Pretax Income
-4834000
Net Income
-4834000
Eps
-3.01040689068063
Dividends Per Share
-
Shares Outstanding
1605763
Income Tax Expense
-227000
EBITDA
-6065000
Operating Margin
-
Total Other Income Expense Net
1275000
Cash
16035000
Short Term Investments
-
Receivables
-
Inventories
-
Total Current Assets
17279000
Property Plant Equipment
25948000
Total Assets
45576000
Payables
29000
Short Term Debt
4187999
Long Term Debt
-
Total Liabilities
31357000
Equity
14219000
Depreciation
44000
Change In Working Capital
-528000
Cash From Operations
-4726000
Capital Expenditures
0
Cash From Investing
-
Cash From Financing
0
Net Change In Cash
-4726000
PE
-
PB
1.5313416048948592
ROE
-33.99676489204585
ROA
-10.606459540108828
FCF
-4726000
Fcf Percent
-
Piotroski FScore
1
Health Score
29
Deep Value Investing Score
3
Defensive Investing Score
5.5
Dividend Investing Score
1.5
Economic Moat Investing Score
3.8
Garp Investing Score
1
Growth Investing Score
1
Momentum Investing Score
5
Net Net Investing Score
3.5
Quality Investing Score
1
Value Investing Score
3
Quarters > 0 > quarter
2024-06-30
Quarters > 0 > income Statement > revenue
0
Quarters > 0 > income Statement > cost Of Revenue
44000
Quarters > 0 > income Statement > gross Profit
-44000
Quarters > 0 > income Statement > operating Expenses
6109000
Quarters > 0 > income Statement > operating Income
-6109000
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
-4834000
Quarters > 0 > income Statement > net Income
-4834000
Quarters > 0 > income Statement > eps
-3.01040689068063
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
1605763
Quarters > 0 > income Statement > income Tax Expense
-227000
Quarters > 0 > income Statement > EBITDA
-6065000
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
1275000
Quarters > 0 > balance Sheet > cash
16035000
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
-
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
17279000
Quarters > 0 > balance Sheet > property Plant Equipment
25948000
Quarters > 0 > balance Sheet > total Assets
45576000
Quarters > 0 > balance Sheet > payables
29000
Quarters > 0 > balance Sheet > short Term Debt
4187999
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
31357000
Quarters > 0 > balance Sheet > equity
14219000
Quarters > 0 > cash Flow > net Income
-4834000
Quarters > 0 > cash Flow > depreciation
44000
Quarters > 0 > cash Flow > change In Working Capital
-528000
Quarters > 0 > cash Flow > cash From Operations
-4726000
Quarters > 0 > cash Flow > capital Expenditures
0
Quarters > 0 > cash Flow > cash From Investing
-
Quarters > 0 > cash Flow > cash From Financing
0
Quarters > 0 > cash Flow > net Change In Cash
-4726000
Quarters > 0 > ratios > PE
-3.01040689068063
Quarters > 0 > ratios > PB
1.5313416048948592
Quarters > 0 > ratios > ROE
-33.99676489204585
Quarters > 0 > ratios > ROA
-10.606459540108828
Quarters > 0 > ratios > FCF
-4726000
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
29
Quarters > 1 > quarter
2024-03-31
Quarters > 1 > income Statement > revenue
2845000
Quarters > 1 > income Statement > cost Of Revenue
43000
Quarters > 1 > income Statement > gross Profit
-43000
Quarters > 1 > income Statement > operating Expenses
5121000
Quarters > 1 > income Statement > operating Income
-5164000
Quarters > 1 > income Statement > interest Expense
280000
Quarters > 1 > income Statement > pretax Income
-3876000
Quarters > 1 > income Statement > net Income
-3876000
Quarters > 1 > income Statement > eps
-2.4138057733301865
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
1605763
Quarters > 1 > income Statement > income Tax Expense
-276
Quarters > 1 > income Statement > EBITDA
-5121000
Quarters > 1 > income Statement > operating Margin
-181.51142355008787
Quarters > 1 > income Statement > total Other Income Expense Net
1288000
Quarters > 1 > balance Sheet > cash
20762000
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
-
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
21175000
Quarters > 1 > balance Sheet > property Plant Equipment
26569000
Quarters > 1 > balance Sheet > total Assets
50092000
Quarters > 1 > balance Sheet > payables
47000
Quarters > 1 > balance Sheet > short Term Debt
4016000
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
31054000
Quarters > 1 > balance Sheet > equity
19038000
Quarters > 1 > cash Flow > net Income
-3876000
Quarters > 1 > cash Flow > depreciation
43000
Quarters > 1 > cash Flow > change In Working Capital
-1123000
Quarters > 1 > cash Flow > cash From Operations
-4362000
Quarters > 1 > cash Flow > capital Expenditures
14000
Quarters > 1 > cash Flow > cash From Investing
51000
Quarters > 1 > cash Flow > cash From Financing
0
Quarters > 1 > cash Flow > net Change In Cash
-4362000
Quarters > 1 > ratios > PE
-2.4138057733301865
Quarters > 1 > ratios > PB
1.1437202584305075
Quarters > 1 > ratios > ROE
-20.35928143712575
Quarters > 1 > ratios > ROA
-7.737762516968777
Quarters > 1 > ratios > FCF
-4376000
Quarters > 1 > ratios > Piotroski FScore
0
Quarters > 1 > ratios > fcf Percent
-1.5381370826010545
Quarters > 1 > health Score
24
Quarters > 2 > quarter
2023-12-31
Quarters > 2 > income Statement > revenue
2845000
Quarters > 2 > income Statement > cost Of Revenue
44000
Quarters > 2 > income Statement > gross Profit
-44000
Quarters > 2 > income Statement > operating Expenses
4637000
Quarters > 2 > income Statement > operating Income
-4681000
Quarters > 2 > income Statement > interest Expense
98024000
Quarters > 2 > income Statement > pretax Income
-3041000
Quarters > 2 > income Statement > net Income
-3041000
Quarters > 2 > income Statement > eps
-1.8938037555978062
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
1605763
Quarters > 2 > income Statement > income Tax Expense
1177000
Quarters > 2 > income Statement > EBITDA
-4637000
Quarters > 2 > income Statement > operating Margin
-164.53427065026364
Quarters > 2 > income Statement > total Other Income Expense Net
1640000
Quarters > 2 > balance Sheet > cash
25124000
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
0
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
25847000
Quarters > 2 > balance Sheet > property Plant Equipment
27178000
Quarters > 2 > balance Sheet > total Assets
70997000
Quarters > 2 > balance Sheet > payables
141000
Quarters > 2 > balance Sheet > short Term Debt
3446000
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
48111000
Quarters > 2 > balance Sheet > equity
22886000
Quarters > 2 > cash Flow > net Income
-3041000
Quarters > 2 > cash Flow > depreciation
44000
Quarters > 2 > cash Flow > change In Working Capital
-786000
Quarters > 2 > cash Flow > cash From Operations
-3706000
Quarters > 2 > cash Flow > capital Expenditures
14000
Quarters > 2 > cash Flow > cash From Investing
51000
Quarters > 2 > cash Flow > cash From Financing
0
Quarters > 2 > cash Flow > net Change In Cash
-3655000
Quarters > 2 > ratios > PE
-1.8938037555978062
Quarters > 2 > ratios > PB
0.9514177348597397
Quarters > 2 > ratios > ROE
-13.287599405750242
Quarters > 2 > ratios > ROA
-4.283279575193318
Quarters > 2 > ratios > FCF
-3720000
Quarters > 2 > ratios > Piotroski FScore
0
Quarters > 2 > ratios > fcf Percent
-1.3075571177504393
Quarters > 2 > health Score
19
Quarters > 3 > quarter
2023-09-30
Quarters > 3 > income Statement > revenue
0
Quarters > 3 > income Statement > cost Of Revenue
52000
Quarters > 3 > income Statement > gross Profit
-52000
Quarters > 3 > income Statement > operating Expenses
3781000
Quarters > 3 > income Statement > operating Income
-3781000
Quarters > 3 > income Statement > interest Expense
392000
Quarters > 3 > income Statement > pretax Income
-2416000
Quarters > 3 > income Statement > net Income
-2416000
Quarters > 3 > income Statement > eps
-1.5053269008023218
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
1604967
Quarters > 3 > income Statement > income Tax Expense
-52000
Quarters > 3 > income Statement > EBITDA
-3683000
Quarters > 3 > income Statement > operating Margin
-
Quarters > 3 > income Statement > total Other Income Expense Net
1365000
Quarters > 3 > balance Sheet > cash
28779000
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
0
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
29919000
Quarters > 3 > balance Sheet > property Plant Equipment
27226000
Quarters > 3 > balance Sheet > total Assets
59493000
Quarters > 3 > balance Sheet > payables
357000
Quarters > 3 > balance Sheet > short Term Debt
3942000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
33680000
Quarters > 3 > balance Sheet > equity
25813000
Quarters > 3 > cash Flow > net Income
-2416000
Quarters > 3 > cash Flow > depreciation
52000
Quarters > 3 > cash Flow > change In Working Capital
-3973000
Quarters > 3 > cash Flow > cash From Operations
-5261000
Quarters > 3 > cash Flow > capital Expenditures
0
Quarters > 3 > cash Flow > cash From Investing
20000
Quarters > 3 > cash Flow > cash From Financing
0
Quarters > 3 > cash Flow > net Change In Cash
-5242000
Quarters > 3 > ratios > PE
-1.5053269008023218
Quarters > 3 > ratios > PB
0.8431159694727464
Quarters > 3 > ratios > ROE
-9.359624995157478
Quarters > 3 > ratios > ROA
-4.060981964264703
Quarters > 3 > ratios > FCF
-5261000
Quarters > 3 > ratios > Piotroski FScore
0
Quarters > 3 > ratios > fcf Percent
-
Quarters > 3 > health Score
31
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
-
Annuals > 0 > income Statement > cost Of Revenue
174000
Annuals > 0 > income Statement > gross Profit
-174000
Annuals > 0 > income Statement > operating Expenses
18685000
Annuals > 0 > income Statement > operating Income
-18859000
Annuals > 0 > income Statement > interest Expense
-
Annuals > 0 > income Statement > pretax Income
-13877000
Annuals > 0 > income Statement > net Income
-13877000
Annuals > 0 > income Statement > eps
-8.641997604876934
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
1605763
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-13703000
Annuals > 0 > income Statement > operating Margin
-
Annuals > 0 > income Statement > total Other Income Expense Net
4982000
Annuals > 0 > balance Sheet > cash
10262000
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
-
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
10766000
Annuals > 0 > balance Sheet > property Plant Equipment
24668000
Annuals > 0 > balance Sheet > total Assets
49750000
Annuals > 0 > balance Sheet > payables
148000
Annuals > 0 > balance Sheet > short Term Debt
2260000
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
40671000
Annuals > 0 > balance Sheet > equity
9079000
Annuals > 0 > cash Flow > net Income
-
Annuals > 0 > cash Flow > depreciation
174000
Annuals > 0 > cash Flow > change In Working Capital
-
Annuals > 0 > cash Flow > cash From Operations
-
Annuals > 0 > cash Flow > capital Expenditures
-
Annuals > 0 > cash Flow > cash From Investing
-
Annuals > 0 > cash Flow > cash From Financing
-
Annuals > 0 > cash Flow > net Change In Cash
-
Annuals > 0 > ratios > PE
-8.641997604876934
Annuals > 0 > ratios > PB
2.3885702516797003
Annuals > 0 > ratios > ROE
-152.84722987113116
Annuals > 0 > ratios > ROA
-27.89346733668342
Annuals > 0 > ratios > FCF
-
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-
Annuals > 0 > health Score
24
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
107000
Annuals > 1 > income Statement > cost Of Revenue
1520000
Annuals > 1 > income Statement > gross Profit
-1413000
Annuals > 1 > income Statement > operating Expenses
32589000
Annuals > 1 > income Statement > operating Income
-34002000
Annuals > 1 > income Statement > interest Expense
-
Annuals > 1 > income Statement > pretax Income
-78215000
Annuals > 1 > income Statement > net Income
-74754000
Annuals > 1 > income Statement > eps
-46.588792240062475
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
1604549
Annuals > 1 > income Statement > income Tax Expense
-3461000
Annuals > 1 > income Statement > EBITDA
-32482000
Annuals > 1 > income Statement > operating Margin
-31777.570093457944
Annuals > 1 > income Statement > total Other Income Expense Net
-44213000
Annuals > 1 > balance Sheet > cash
25124000
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
0
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
25847000
Annuals > 1 > balance Sheet > property Plant Equipment
27178000
Annuals > 1 > balance Sheet > total Assets
55373000
Annuals > 1 > balance Sheet > payables
141000
Annuals > 1 > balance Sheet > short Term Debt
3446000
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
32487000
Annuals > 1 > balance Sheet > equity
22886000
Annuals > 1 > cash Flow > net Income
-74754000
Annuals > 1 > cash Flow > depreciation
1520000
Annuals > 1 > cash Flow > change In Working Capital
-5420000
Annuals > 1 > cash Flow > cash From Operations
-31505000
Annuals > 1 > cash Flow > capital Expenditures
65000
Annuals > 1 > cash Flow > cash From Investing
1327000
Annuals > 1 > cash Flow > cash From Financing
-16155000
Annuals > 1 > cash Flow > net Change In Cash
-46333000
Annuals > 1 > ratios > PE
-46.588792240062475
Annuals > 1 > ratios > PB
0.9468423597395789
Annuals > 1 > ratios > ROE
-326.63637158087914
Annuals > 1 > ratios > ROA
-135.00081267043504
Annuals > 1 > ratios > FCF
-31570000
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-295.04672897196264
Annuals > 1 > health Score
23
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
861000
Annuals > 2 > income Statement > cost Of Revenue
5507000
Annuals > 2 > income Statement > gross Profit
-4646000
Annuals > 2 > income Statement > operating Expenses
90474000
Annuals > 2 > income Statement > operating Income
-95120000
Annuals > 2 > income Statement > interest Expense
35439000
Annuals > 2 > income Statement > pretax Income
-114646000
Annuals > 2 > income Statement > net Income
-114646000
Annuals > 2 > income Statement > eps
-72.11705701818117
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
1589721
Annuals > 2 > income Statement > income Tax Expense
-947000
Annuals > 2 > income Statement > EBITDA
-82687000
Annuals > 2 > income Statement > operating Margin
-11047.619047619048
Annuals > 2 > income Statement > total Other Income Expense Net
-19526000
Annuals > 2 > balance Sheet > cash
71038000
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
144000
Annuals > 2 > balance Sheet > inventories
-3513000
Annuals > 2 > balance Sheet > total Current Assets
71038000
Annuals > 2 > balance Sheet > property Plant Equipment
48688000
Annuals > 2 > balance Sheet > total Assets
162939000
Annuals > 2 > balance Sheet > payables
1097000
Annuals > 2 > balance Sheet > short Term Debt
6868000
Annuals > 2 > balance Sheet > long Term Debt
14653000
Annuals > 2 > balance Sheet > total Liabilities
67228000
Annuals > 2 > balance Sheet > equity
95711000
Annuals > 2 > cash Flow > net Income
-114646000
Annuals > 2 > cash Flow > depreciation
5507000
Annuals > 2 > cash Flow > change In Working Capital
-1564000
Annuals > 2 > cash Flow > cash From Operations
-74851000
Annuals > 2 > cash Flow > capital Expenditures
2182000
Annuals > 2 > cash Flow > cash From Investing
-2182000
Annuals > 2 > cash Flow > cash From Financing
14873000
Annuals > 2 > cash Flow > net Change In Cash
-62160000
Annuals > 2 > ratios > PE
-72.11705701818117
Annuals > 2 > ratios > PB
0.22431258794704892
Annuals > 2 > ratios > ROE
-119.78351495648359
Annuals > 2 > ratios > ROA
-70.36130085492117
Annuals > 2 > ratios > FCF
-77033000
Annuals > 2 > ratios > Piotroski FScore
1
Annuals > 2 > ratios > fcf Percent
-89.46922183507549
Annuals > 2 > health Score
30
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
18532000
Annuals > 3 > income Statement > cost Of Revenue
57279000
Annuals > 3 > income Statement > gross Profit
18532000
Annuals > 3 > income Statement > operating Expenses
78517000
Annuals > 3 > income Statement > operating Income
-59985000
Annuals > 3 > income Statement > interest Expense
2301000
Annuals > 3 > income Statement > pretax Income
-58160000
Annuals > 3 > income Statement > net Income
-55859000
Annuals > 3 > income Statement > eps
-35.270331790781185
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
1583739
Annuals > 3 > income Statement > income Tax Expense
-2301000
Annuals > 3 > income Statement > EBITDA
-57684000
Annuals > 3 > income Statement > operating Margin
-323.6833585150011
Annuals > 3 > income Statement > total Other Income Expense Net
1825000
Annuals > 3 > balance Sheet > cash
133481000
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
494000
Annuals > 3 > balance Sheet > inventories
-9070000
Annuals > 3 > balance Sheet > total Current Assets
142551000
Annuals > 3 > balance Sheet > property Plant Equipment
24688000
Annuals > 3 > balance Sheet > total Assets
225369000
Annuals > 3 > balance Sheet > payables
3737000
Annuals > 3 > balance Sheet > short Term Debt
2256000
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
23145000
Annuals > 3 > balance Sheet > equity
202224000
Annuals > 3 > cash Flow > net Income
-58160000
Annuals > 3 > cash Flow > depreciation
2301000
Annuals > 3 > cash Flow > change In Working Capital
-14512000
Annuals > 3 > cash Flow > cash From Operations
-67133000
Annuals > 3 > cash Flow > capital Expenditures
15983000
Annuals > 3 > cash Flow > cash From Investing
-15921000
Annuals > 3 > cash Flow > cash From Financing
119110000
Annuals > 3 > cash Flow > net Change In Cash
36056000
Annuals > 3 > ratios > PE
-35.270331790781185
Annuals > 3 > ratios > PB
0.10576585961606931
Annuals > 3 > ratios > ROE
-27.62233958382783
Annuals > 3 > ratios > ROA
-24.78557388105729
Annuals > 3 > ratios > FCF
-83116000
Annuals > 3 > ratios > Piotroski FScore
1
Annuals > 3 > ratios > fcf Percent
-4.484998920785668
Annuals > 3 > health Score
34
Valuation > metrics > PE
-3.01040689068063
Valuation > metrics > PB
1.5313416048948592
Valuation > final Score
80
Valuation > verdict
Fair
Profitability > metrics > ROE
-33.99676489204585
Profitability > metrics > ROA
-27.976156027547887
Profitability > final Score
15
Profitability > verdict
Weak
Risk > metrics > Debt Equity
2.2052886982206905
Risk > metrics > Interest Coverage
-4.962632006498781
Risk > final Score
-2
Risk > verdict
High
Liquidity > metrics > Current Ratio
4.097463622827513
Liquidity > metrics > Quick Ratio
4.097463622827513
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
80
Prev Valuations > 1
70
Prev Valuations > 2
70
Prev Profitabilities > 0
0
Prev Profitabilities > 1
0
Prev Profitabilities > 2
15
Prev Risks > 0
-44
Prev Risks > 1
18
Prev Risks > 2
-9
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2025-12-14T00:29:42.701Z
Earnings History > 0 > period
2024-06-30
Earnings History > 0 > report Date
2024-08-13
Earnings History > 0 > date
2024-06-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
USD
Earnings History > 0 > eps Actual
-3.01
Earnings History > 0 > eps Estimate
-
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2024-03-31
Earnings History > 1 > report Date
2024-05-10
Earnings History > 1 > date
2024-03-31
Earnings History > 1 > before After Market
AfterMarket
Earnings History > 1 > currency
USD
Earnings History > 1 > eps Actual
-2.4138
Earnings History > 1 > eps Estimate
-
Earnings History > 1 > eps Difference
0
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2023-12-31
Earnings History > 2 > report Date
2024-03-25
Earnings History > 2 > date
2023-12-31
Earnings History > 2 > before After Market
AfterMarket
Earnings History > 2 > currency
USD
Earnings History > 2 > eps Actual
-1.8938
Earnings History > 2 > eps Estimate
-
Earnings History > 2 > eps Difference
0
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2023-09-30
Earnings History > 3 > report Date
2023-11-08
Earnings History > 3 > date
2023-09-30
Earnings History > 3 > before After Market
BeforeMarket
Earnings History > 3 > currency
USD
Earnings History > 3 > eps Actual
-1.5053
Earnings History > 3 > eps Estimate
-
Earnings History > 3 > eps Difference
0
Earnings History > 3 > surprise Percent
-
Earnings History > 4 > period
2023-06-30
Earnings History > 4 > report Date
2023-08-10
Earnings History > 4 > date
2023-06-30
Earnings History > 4 > before After Market
BeforeMarket
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-3.24
Earnings History > 4 > eps Estimate
-4.5
Earnings History > 4 > eps Difference
1.26
Earnings History > 4 > surprise Percent
28
Earnings History > 5 > period
2023-03-31
Earnings History > 5 > report Date
2023-05-10
Earnings History > 5 > date
2023-03-31
Earnings History > 5 > before After Market
BeforeMarket
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-0.38
Earnings History > 5 > eps Estimate
-0.09
Earnings History > 5 > eps Difference
-0.29
Earnings History > 5 > surprise Percent
-322.2222
Earnings History > 6 > period
2022-12-31
Earnings History > 6 > report Date
2023-03-23
Earnings History > 6 > date
2022-12-31
Earnings History > 6 > before After Market
AfterMarket
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-0.56
Earnings History > 6 > eps Estimate
-0.34
Earnings History > 6 > eps Difference
-0.22
Earnings History > 6 > surprise Percent
-64.7059
Earnings History > 7 > period
2022-09-30
Earnings History > 7 > report Date
2022-11-10
Earnings History > 7 > date
2022-09-30
Earnings History > 7 > before After Market
BeforeMarket
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-0.85
Earnings History > 7 > eps Estimate
-0.4
Earnings History > 7 > eps Difference
-0.45
Earnings History > 7 > surprise Percent
-112.5
Earnings History > 8 > period
2022-06-30
Earnings History > 8 > report Date
2022-08-11
Earnings History > 8 > date
2022-06-30
Earnings History > 8 > before After Market
BeforeMarket
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-0.48
Earnings History > 8 > eps Estimate
-0.41
Earnings History > 8 > eps Difference
-0.07
Earnings History > 8 > surprise Percent
-17.0732
Earnings History > 9 > period
2022-03-31
Earnings History > 9 > report Date
2022-05-16
Earnings History > 9 > date
2022-03-31
Earnings History > 9 > before After Market
BeforeMarket
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-0.52
Earnings History > 9 > eps Estimate
-
Earnings History > 9 > eps Difference
0
Earnings History > 9 > surprise Percent
-
Earnings History > 10 > period
2021-12-31
Earnings History > 10 > report Date
2022-03-31
Earnings History > 10 > date
2021-12-31
Earnings History > 10 > before After Market
AfterMarket
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-0.4
Earnings History > 10 > eps Estimate
-0.32
Earnings History > 10 > eps Difference
-0.08
Earnings History > 10 > surprise Percent
-25
Earnings History > 11 > period
2021-09-30
Earnings History > 11 > report Date
2021-11-10
Earnings History > 11 > date
2021-09-30
Earnings History > 11 > before After Market
BeforeMarket
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
-0.21
Earnings History > 11 > eps Estimate
-0.42
Earnings History > 11 > eps Difference
0.21
Earnings History > 11 > surprise Percent
50
Earnings History > 12 > period
2021-06-30
Earnings History > 12 > report Date
2021-08-10
Earnings History > 12 > date
2021-06-30
Earnings History > 12 > before After Market
BeforeMarket
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
-0.32
Earnings History > 12 > eps Estimate
-0.28
Earnings History > 12 > eps Difference
-0.04
Earnings History > 12 > surprise Percent
-14.2857
Earnings History > 13 > period
2021-03-31
Earnings History > 13 > report Date
2021-05-13
Earnings History > 13 > date
2021-03-31
Earnings History > 13 > before After Market
BeforeMarket
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
-1
Earnings History > 13 > eps Estimate
-0.24
Earnings History > 13 > eps Difference
-0.76
Earnings History > 13 > surprise Percent
-316.6667
Earnings History > 14 > period
2020-12-31
Earnings History > 14 > report Date
2021-01-09
Earnings History > 14 > date
2020-12-31
Earnings History > 14 > before After Market
AfterMarket
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
-0.28
Earnings History > 14 > eps Estimate
0
Earnings History > 14 > eps Difference
-0.28
Earnings History > 14 > surprise Percent
-
Finch Therapeutics Group, Inc., a clinical-stage microbiome therapeutics company, develops a novel class of orally administered biological drugs in the United States. The company develops FIN-211, a microbiome candidate designed to address the gastrointestinal and behavioral symptoms of autism spectrum disorder; and FIN-524 for the prevention, diagnosis, theragnosis or treatment of diseases in humans, including ulcerative colitis; FIN-525 for the treatment of Crohn's disease; and other microbiome product candidates. The company has collaboration and license agreements with Takeda Pharmaceutical Company Limited; and license agreements with Skysong Innovations LLC, OpenBiome, Arizona State University, and University of Minnesota. Finch Therapeutics Group, Inc. was incorporated in 2014 and is based in Boston, Massachusetts.
Stock Price
$ 0.00
0% decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AFinch Therapeutics Group (NASDAQ:FNCH) Trading Down 3.9% – Should You Sell? - Defense World
12/16/2025
Finch Therapeutics Group (NASDAQ:FNCH) Trading Down 3.9% – Should You Sell? Defense World
Read more →Showing 2 of 10
(Last Updated 2024-06-30)
Rating:
BUY
Target Price:
$90
Analyst Picks
Strong Buy
0
Buy
1
Hold
0
Sell
0
Strong Sell
0
(Last Updated 2024-06-30)
Health Score
Price to Book Ratio (P/B)
-
Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Debt to Equity
-
Very Low
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 9.99% of the total shares of Finch Therapeutics Group Inc
1.
Susquehanna International Group, LLP(3.676%)
since
2023/12/31
2.
Vanguard Group Inc(2.2576%)
since
2024/03/31
3.
Vanguard Institutional Extnd Mkt Idx Tr(1.011%)
since
2024/04/30
4.
Renaissance Technologies Corp(0.7315%)
since
2023/12/31
5.
Vanguard Total Stock Mkt Idx Inv(0.6045%)
since
2024/04/30
6.
Greenwich Ivy Long-Short Instl(0.4669%)
since
2023/12/31
7.
Ikarian Capital, LLC(0.4292%)
since
2024/03/31
8.
Fidelity Extended Market Index(0.2312%)
since
2024/03/31
9.
Tower Research Capital LLC(0.1635%)
since
2023/12/31
10.
Fidelity Total Market Index(0.1001%)
since
2024/03/31
11.
Bleichroeder LP(0.0605%)
since
2024/03/31
12.
Fidelity Nasdaq Composite Index(0.0529%)
since
2024/03/31
13.
Northern Trust Extended Eq Market Idx(0.0356%)
since
2024/03/31
14.
NT Ext Equity Mkt Idx Fd - L(0.0356%)
since
2024/03/31
15.
Spartan Total Market Index Pool E(0.0301%)
since
2024/03/31
16.
BlackRock Inc(0.0212%)
since
2023/12/31
17.
NT Ext Equity Mkt Idx Fd - NL(0.0149%)
since
2024/03/31
18.
Fidelity Series Total Market Index(0.0145%)
since
2024/03/31
19.
NT Ext Equity Mkt Idx Fd - DC - NL - T2(0.012%)
since
2023/12/31
20.
Northwestern Mutual Wealth Management Co(0.0088%)
since
2023/12/31
21.
Morgan Stanley - Brokerage Accounts(0.0077%)
since
2023/12/31
22.
State St US Extended Mkt Indx NL Cl C(0.0066%)
since
2024/04/30
23.
SSgA U.S. Extended Market Index Class I(0.0066%)
since
2023/12/31
24.
SSgA U.S. Total Market Index Strategy(0.0019%)
since
2023/12/31
25.
State St US Ttl Mkt Indx SL Cl I(0.0019%)
since
2024/04/30
26.
Royal Bank of Canada(0.0017%)
since
2023/12/31
27.
Northern Trust Wilshire 5000(0.0017%)
since
2024/03/31
28.
NT US Market Cap Idx Fd - L(0.0017%)
since
2023/12/31
29.
NT Ext Eq Mkt Indx Fd DC Lending Tier 5(0.0014%)
since
2024/03/31
30.
BlackRock Extended Mkt Composite(0.0009%)
since
2023/09/30
31.
Bank of America Corp(0.0007%)
since
2023/12/31
32.
Wells Fargo & Co(0.0004%)
since
2023/12/31
33.
Moisand Fitzgerald Tamayo, LLC(0.0002%)
since
2023/12/31
34.
Cutler Group LP(0.0002%)
since
2023/12/31
35.
UBS Group AG(0.0001%)
since
2023/12/31
36.
MSD Partners, L.P.(0%)
since
2023/12/31
37.
LAKE STREET ADVISORS GROUP, LLC(0%)
since
2023/12/31
38.
Ancora Advisors LLC(0%)
since
2023/12/31
39.
Steward Partners Investment Advisory, LLC(0%)
since
2023/12/31
40.
Baupost Group LLC(0%)
since
2024/03/31
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2024-06-30
EPS Actual
-3.01
EPS Estimate
—
EPS Difference
0
Surprise Percent
null%
(Last Updated 2024-06-30)
(Last Updated 2024-06-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2024-06-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2024-06-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.